Pfizer Stock

• Pfizer shares sink on declining demand for COVID vaccines, treatment

  Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand for COVID vaccines and treatment.

  Consumer

  Dec 13, 2023
  
• Pfizer reports 1st quarterly loss since 2019 on weak COVID product demand

  Pfizer on Tuesday reported weak demand for its COVID vaccine and treatment, which pushed the drugmaker to its first quarterly loss since 2019.

  Health

  Oct 31, 2023
  
• Advertisement
• New COVID shots effective against latest variant, Pfizer and Moderna say

  Pfizer said its updated COVID vaccine elicited a strong antibody response against BA.2.86 in a preclinical study. Moderna said its new shot was also effective against the variant.

  Health

  Sep 6, 2023
• Advertisement
• Pfizer sees promising results from antibiotic combo for superbug infections

  Deaths from antibiotic-resistant bacteria have been on the rise globally, prompting calls for the development of newer treatments as resistance to older antibiotics grows.

  Health

  Jun 1, 2023
• Pfizer CEO says 2023 will be ‘transition year’ as it sees drop in COVID sales

  Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products.

  Money

  Jan 31, 2023
• Pfizer to seek U.S. approval for 2nd COVID booster for people 65 and older: report

  Pfizer's submission to the U.S. Food and Drug Administration is anticipated as soon as Tuesday.

  Health

  Mar 15, 2022
• Pfizer to buy Arena Pharmaceuticals as it expands treatment pipeline

  This is the latest deal Pfizer has struck this year to expand treatment pipeline.

  Health

  Dec 13, 2021
• Pfizer expects $29B in COVID-19 vaccine sales next year

  Pfizer's COVID-19 vaccine has become one of the most widely used inoculation in the United States and Europe, and its sales has outpaced that of its rivals.

  Money

  Nov 2, 2021
• Advertisement
• COVID-19 pill developers aim to rival Pfizer, Merck treatments

  Infectious disease experts stressed that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic.

  Health

  Sep 28, 2021
• Advertisement
• Pfizer launches large study of oral COVID-19 prevention drug

  Pfizer and its rivals have been racing to develop an easy-to-administer antiviral pill for COVID-19.

  Health

  Sep 27, 2021